Breakdown of Cancer Treatment Helpline use by tumour group from 2017 to 2020
| Tumour group | 2017 | 2018 | 2019 | 2020 | Total | % change |
| Breast | 295 (21%) | 387 (22%) | 477 (24%) | 465 (22%) | 1624 (22%) | 58 |
| Lung | 305 (21%) | 405 (23%) | 413 (21%) | 408 (20%) | 1531 (21%) | 38 |
| Lower GI | 167 (12%) | 240 (14%) | 264 (13%) | 276 (13%) | 947 (13%) | 65 |
| Gynae | 191 (13%) | 183 (10%) | 220 (11%) | 203 (10%) | 797 (11%) | 6 |
| Upper GI | 173 (12%) | 155 (9%) | 170 (9%) | 263 (13%) | 761 (10%) | 52 |
| Prostate | 105 (7%) | 101 (6%) | 105 (5%) | 80 (4%) | 391 (5%) | −24 |
Only tumour groups with more than 100 calls in 2017 are shown. The percentage (%) change from 2017 to 2020 is recorded.
GI, gastrointestinal.